ag-1296 has been researched along with Carcinoma 256, Walker in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mousseau, Y | 1 |
| Mollard, S | 1 |
| Faucher-Durand, K | 1 |
| Richard, L | 1 |
| Nizou, A | 1 |
| Cook-Moreau, J | 1 |
| Baaj, Y | 1 |
| Qiu, H | 1 |
| Plainard, X | 1 |
| Fourcade, L | 1 |
| Funalot, B | 1 |
| Sturtz, FG | 1 |
1 other study available for ag-1296 and Carcinoma 256, Walker
| Article | Year |
|---|---|
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma 256, Walker; Cel | 2012 |